The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast

Webcast


10 / 111 sonuç bulundu

{%SMALL_TITLE%}
{%SUMMARY_INFO%}

{%BOTTOM_TEXT%}

{%SMALL_TITLE%}

{%EXCERPT%}

{%BOTTOM_TEXT%}

Speaker
Silke Brix, United Kingdom

Panellists
Ingeborg Bajema, The Netherlands
Zdenka Hruskova, Czech Republic

Moderator
Annette Bruchfeld, Sweden

IWG WG